Clinical Case Study: TC Biopharma’s Clinical Update
Time: 1:45 pm
day: Conference Day One - Track B - Afternoon
Details:
- Defining clear inclusion and exclusion criteria and previous treatments to ensure a homogeneous patient population
- Characterizing gamma delta T cells
- Implementing dose-escalation protocols, balancing safety, and efficacy in early phases of the clinical trial
